Onglyza (Saxagliptin) Linked to Life-Threatening Heart Problems

Onglyza (containing saxagliptin) is a medication marketed to type 2 diabetes sufferers to manage their symptoms. Onglyza has been linked to an increased risk for heart failure (particularly among individuals with type 2 diabetes who also suffer from heart or kidney disease).

If you or someone you know has been prescribed Onglyza and you are experiencing the following symptoms, please contact your physician immediately:

  • Shortness of breath while engaging in everyday activities
  • Difficulty breathing while lying down
  • Drowsiness, fatigue, or weakness
  • Weight gain
  • Swelling in the ankles, feet, legs, and/or stomach regions

Those currently taking Onglyza should consult a medical professional prior to discontinuing use of the medication. If you or someone your care for has suffered an injury related to the use of Onglyza, please contact Inserra | Kelley | Sewell, Injury Attorneys for expert guidance and assistance recovering compensation for your injuries. Our experienced team of legal professionals are well-known for getting to the heart of the most painful liability/injury issues that our clients look to us to resolve.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply

Your email address will not be published. Required fields are marked *